Standout Papers

The safety profile of infliximab in patients with Crohn’s disea... 1992 2026 2003 2014 662
  1. The safety profile of infliximab in patients with Crohn’s disease: The Mayo Clinic experience in 500 patients (2003)
    Jean‐Frédéric Colombel, Edward V. Loftus et al. Gastroenterology
  2. Dyspepsia and dyspepsia subgroups: A population-based study (1992)
    Nicholas J. Talley, Alan R. Zinsmeister et al. Gastroenterology

Immediate Impact

1 by Nobel laureates 6 from Science/Nature 83 standout
Sub-graph 1 of 17

Citing Papers

Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?
2021 Standout
Diagnosis and Treatment of Irritable Bowel Syndrome
2021 Standout
16 intermediate papers

Works of Cathy D. Schleck being referenced

A case-control comparison of direct healthcare-provider medical costs of chronic idiopathic constipation and irritable bowel syndrome with constipation in a community-based cohort
2016
Natural History of Functional Gastrointestinal Disorders: A 12-year Longitudinal Population-Based Study
2007
and 15 more

Author Peers

Author Last Decade Papers Cites
Cathy D. Schleck 10988 4965 3628 256 17.4k
L. Joseph Melton 11479 4213 5397 174 24.7k
Joe West 3183 3608 2631 202 10.3k
John H. Pembérton 8765 3526 2888 232 13.3k
Marcel G. W. Dijkgraaf 4641 2877 1200 296 12.4k
William S. Harmsen 14914 10118 2221 601 30.0k
Yves Panís 11117 3157 690 402 18.1k
Willem A. Bemelman 12668 2889 1153 421 17.7k
Robert W. Beart 14933 1626 1412 361 22.2k
Alastair Forbes 5474 4263 1392 354 17.7k
Shahnaz Sultan 4086 2395 1143 168 12.2k

All Works

Loading papers...

Rankless by CCL
2026